Yes, bubonic plague is curable. Antibiotics are highly effective against the bacterium that causes it, and recovery rates are high when treatment begins within 24 hours of the first symptoms. Left untreated, bubonic plague kills 30% to 60% of those infected. With prompt antibiotic treatment, most people survive.
That said, “curable” and “no longer dangerous” are not the same thing. Plague still kills people every year, almost always because treatment started too late or wasn’t available. The difference between life and death with this disease comes down to speed.
How Antibiotics Cure Plague
The plague bacterium, Yersinia pestis, is vulnerable to several classes of antibiotics. Some of these drugs kill the bacteria directly by disrupting their ability to build proteins, while others slow bacterial growth enough for the immune system to finish the job. The distinction matters clinically: drugs that kill bacteria outright work even in patients whose immune systems are weakened, while those that only slow growth depend on a functioning immune response to clear the infection completely.
The WHO updated its plague treatment guidelines in 2021, adding a class of antibiotics called fluoroquinolones as a first-line option alongside older standbys. Doctors now have multiple effective drug choices, which provides a safety net if a patient can’t tolerate one type. Treatment typically runs 7 to 14 days, and most patients begin improving within a few days of starting antibiotics.
One critical point the CDC emphasizes, in all capitals on their clinical guidance page: doctors should never wait for lab confirmation before starting treatment. The decision to begin antibiotics is made based on symptoms and the patient’s history alone. Plague progresses fast enough that waiting even a day for test results can be the difference between a routine recovery and a fatal outcome.
Why Timing Is Everything
The best outcomes happen when antibiotics start within 24 hours of symptoms appearing. Bubonic plague typically announces itself with sudden fever, chills, headache, and a painful, swollen lymph node (called a bubo) near the site of a flea bite, usually in the groin, armpit, or neck. The swelling can reach the size of a chicken egg and is often excruciatingly tender.
If the infection stays in the lymph nodes, antibiotics can handle it relatively easily. The danger is what happens without treatment: bacteria spill into the bloodstream, causing septicemic plague, or reach the lungs, causing pneumonic plague. Pneumonic plague is always fatal without treatment and can spread person to person through respiratory droplets. At that stage, even with antibiotics, survival becomes less certain and patients often need intensive hospital care including IV fluids, oxygen, and medications to maintain blood pressure.
Where Plague Still Kills
Plague hasn’t disappeared. The WHO reports cases every year, concentrated in Madagascar, the Democratic Republic of Congo, and Peru, with occasional cases in the western United States. Between 1 and 17 cases occur in the U.S. annually, mostly in rural areas of New Mexico, Arizona, and Colorado where wild rodents carry infected fleas.
Deaths from plague in the modern era almost always trace back to one of two problems: the patient lived in an area without quick access to medical care, or neither the patient nor their doctor recognized the disease fast enough. In the U.S., plague is rare enough that some doctors have never seen a case, which can delay diagnosis. In parts of sub-Saharan Africa and Madagascar, outbreaks can overwhelm local health systems.
The Question of Drug Resistance
One genuine concern is antibiotic resistance. A multidrug-resistant strain of plague was identified in Madagascar, reported by the WHO Collaborating Centre for Yersinia in Paris. The strain resisted multiple standard antibiotics, raising alarms about what would happen if resistant strains became more common.
So far, resistant plague remains extremely rare. The vast majority of Yersinia pestis strains worldwide respond well to standard antibiotics. But the existence of even one resistant case is a reminder that plague’s curability isn’t guaranteed forever, and it’s one reason researchers continue developing new treatment options.
Is There a Vaccine?
No plague vaccine is currently available for general use. An older vaccine existed but was discontinued due to limited effectiveness and significant side effects. As of now, more than 21 vaccine candidates are in development worldwide, with seven having completed mid-stage clinical trials. The WHO has published a target product profile to guide developers, but no candidate has reached the point of widespread approval.
For people at higher risk, such as researchers who work with the bacterium or travelers heading to active outbreak zones, preventive antibiotics can be prescribed after a known exposure. This post-exposure prophylaxis uses the same drugs that treat active infection, started before symptoms develop.
What Recovery Looks Like
For patients who receive antibiotics early, recovery from bubonic plague is straightforward. Fever typically breaks within a few days. The swollen lymph node takes longer to resolve, sometimes weeks, and may occasionally need to be drained if it fills with fluid. Most patients treated promptly make a full recovery with no lasting complications.
Patients who progress to septicemic or pneumonic plague before treatment begins face a harder road. Hospital stays are longer, organ damage is possible, and some patients lose fingers or toes due to tissue death caused by the bacteria. Even with aggressive treatment, these advanced forms carry meaningful mortality rates. The takeaway is consistent across every clinical source: the cure works, but only if it arrives in time.